Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors
Clinical trial NCT04064359 · RECRUITING
Trial details
- NCT number
- NCT04064359
- Sponsor
- Oxford BioTherapeutics Ltd
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-25
- Primary completion
- 2026-12-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.